Macromoltek’s Computational De Novo Antibody Design to Target Covid-19
Computational (in silico) design allows for rapid iteration around potential solutions without the unique variables that traditional in vivo subjects may possess.
Read MoreSearch Results for: liver disease
IAEA to Ship Testing Equipment to Countries in the Fight against Covid-19
Dozens of laboratories in Africa, Asia, Europe, Latin America, and the Caribbean will receive diagnostic machines and kits, reagents, and laboratory consumables
Read MoreLuminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test
The Aries SARS-CoV-2 assay will run on the company’s Aries system, an FDA-cleared, automated molecular diagnostics platform for moderate-complexity labs.
Read More
Assay Detects and Differentiates Trichomonas vaginalis and Mycoplasma genitalium in Urine
The NeuMoDx TV/MG assay implemented on the NeuMoDx Molecular system allows for automated detection of T. vaginalis and M. genitalium simultaneously.
Read MoreProSciento and Nordic Bioscience Partner to Develop Translational Biomarkers for NASH
The partnership will utilize ProSciento’s NASH Pass patient registry and Nordic Bioscience’s biomarker technology to identify and validate translational biomarkers to improve the diagnosis, prognosis, and development of therapeutics for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Read More